BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30566624)

  • 1. Impact of Fgf10 deficiency on pulmonary vasculature formation in a mouse model of bronchopulmonary dysplasia.
    Chao CM; Moiseenko A; Kosanovic D; Rivetti S; El Agha E; Wilhelm J; Kampschulte M; Yahya F; Ehrhardt H; Zimmer KP; Barreto G; Rizvanov AA; Schermuly RT; Reiss I; Morty RE; Rottier RJ; Bellusci S; Zhang JS
    Hum Mol Genet; 2019 May; 28(9):1429-1444. PubMed ID: 30566624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fgf10 deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia.
    Chao CM; Yahya F; Moiseenko A; Tiozzo C; Shrestha A; Ahmadvand N; El Agha E; Quantius J; Dilai S; Kheirollahi V; Jones M; Wilhem J; Carraro G; Ehrhardt H; Zimmer KP; Barreto G; Ahlbrecht K; Morty RE; Herold S; Abellar RG; Seeger W; Schermuly R; Zhang JS; Minoo P; Bellusci S
    J Pathol; 2017 Jan; 241(1):91-103. PubMed ID: 27770432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-421 inhibition alleviates bronchopulmonary dysplasia in a mouse model via targeting Fgf10.
    Yuan HS; Xiong DQ; Huang F; Cui J; Luo H
    J Cell Biochem; 2019 Oct; 120(10):16876-16887. PubMed ID: 31144392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF10 Triggers De Novo Alveologenesis in a Bronchopulmonary Dysplasia Model: Impact on Resident Mesenchymal Niche Cells.
    Taghizadeh S; Chao CM; Guenther S; Glaser L; Gersmann L; Michel G; Kraut S; Goth K; Koepke J; Heiner M; Vazquez-Armendariz AI; Herold S; Samakovlis C; Weissmann N; Ricci F; Aquila G; Boyer L; Ehrhardt H; Minoo P; Bellusci S; Rivetti S
    Stem Cells; 2022 Jun; 40(6):605-617. PubMed ID: 35437594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension (BPD-PH): Potential Role of the FGF Signaling Pathway in the Development of the Pulmonary Vascular System.
    Chao CM; Chong L; Chu X; Shrestha A; Behnke J; Ehrhardt H; Zhang J; Chen C; Bellusci S
    Cells; 2020 Aug; 9(8):. PubMed ID: 32796770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tie-2 Cre-Mediated Deficiency of Extracellular Signal-Regulated Kinase 2 Potentiates Experimental Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Neonatal Mice.
    Menon RT; Shrestha AK; Barrios R; Reynolds C; Shivanna B
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic assessment of pulmonary hypertension using high-resolution echocardiography is feasible in neonatal mice with experimental bronchopulmonary dysplasia and pulmonary hypertension: a step toward preventing chronic obstructive pulmonary disease.
    Reynolds CL; Zhang S; Shrestha AK; Barrios R; Shivanna B
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1597-605. PubMed ID: 27478373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced platelet-derived growth factor receptor expression is a primary feature of human bronchopulmonary dysplasia.
    Popova AP; Bentley JK; Cui TX; Richardson MN; Linn MJ; Lei J; Chen Q; Goldsmith AM; Pryhuber GS; Hershenson MB
    Am J Physiol Lung Cell Mol Physiol; 2014 Aug; 307(3):L231-9. PubMed ID: 24907056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice.
    Hadzic S; Wu CY; Gredic M; Pak O; Loku E; Kraut S; Kojonazarov B; Wilhelm J; Brosien M; Bednorz M; Seimetz M; Günther A; Kosanovic D; Sommer N; Warburton D; Li X; Grimminger F; Ghofrani HA; Schermuly RT; Seeger W; El Agha E; Bellusci S; Weissmann N
    Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37884305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.
    Bhatt AJ; Pryhuber GS; Huyck H; Watkins RH; Metlay LA; Maniscalco WM
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1971-80. PubMed ID: 11734454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Posttranslational modification of β-catenin is associated with pathogenic fibroblastic changes in bronchopulmonary dysplasia.
    Sucre JM; Vijayaraj P; Aros CJ; Wilkinson D; Paul M; Dunn B; Guttentag SH; Gomperts BN
    Am J Physiol Lung Cell Mol Physiol; 2017 Feb; 312(2):L186-L195. PubMed ID: 27941077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor 10-fibroblast growth factor receptor 2b mediated signaling is not required for adult glandular stomach homeostasis.
    Speer AL; Al Alam D; Sala FG; Ford HR; Bellusci S; Grikscheit TC
    PLoS One; 2012; 7(11):e49127. PubMed ID: 23133671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Sphingolipid Signaling in Oxidative Lung Injury and Pathogenesis of Bronchopulmonary Dysplasia.
    Thomas JM; Sudhadevi T; Basa P; Ha AW; Natarajan V; Harijith A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension.
    Bui CB; Kolodziej M; Lamanna E; Elgass K; Sehgal A; Rudloff I; Schwenke DO; Tsuchimochi H; Kroon MAGM; Cho SX; Maksimenko A; Cholewa M; Berger PJ; Young MJ; Bourke JE; Pearson JT; Nold MF; Nold-Petry CA
    Front Immunol; 2019; 10():1480. PubMed ID: 31354700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracheal occlusion increases the rate of epithelial branching of embryonic mouse lung via the FGF10-FGFR2b-Sprouty2 pathway.
    Unbekandt M; del Moral PM; Sala FG; Bellusci S; Warburton D; Fleury V
    Mech Dev; 2008; 125(3-4):314-24. PubMed ID: 18082381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into the expression profiles and functions of circRNAs in a newborn hyperoxia-induced rat bronchopulmonary dysplasia model.
    Cheng H; Wu B; Wang L; Hu T; Deng Z; Li D
    J Gene Med; 2020 May; 22(5):e3163. PubMed ID: 31961470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCR2 Mediates Chronic LPS-Induced Pulmonary Inflammation and Hypoalveolarization in a Murine Model of Bronchopulmonary Dysplasia.
    Cui TX; Brady AE; Fulton CT; Zhang YJ; Rosenbloom LM; Goldsmith AM; Moore BB; Popova AP
    Front Immunol; 2020; 11():579628. PubMed ID: 33117383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Umbilical Cord Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Alleviate Lung Injury in Rat Model of Bronchopulmonary Dysplasia by Affecting Cell Survival and Angiogenesis.
    You J; Zhou O; Liu J; Zou W; Zhang L; Tian D; Dai J; Luo Z; Liu E; Fu Z; Zou L
    Stem Cells Dev; 2020 Dec; 29(23):1520-1532. PubMed ID: 33040709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Vascular Endothelial Growth Factor in Amniotic Fluid Stem Cells Enhances Their Potential to Attenuate Lung Injury in a Preterm Rabbit Model of Bronchopulmonary Dysplasia.
    Jiménez J; Lesage F; Richter J; Nagatomo T; Salaets T; Zia S; Mori Da Cunha MG; Vanoirbeek J; Deprest JA; Toelen J
    Neonatology; 2018; 113(3):275-285. PubMed ID: 29393249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Gender on Mesenchymal Stem Cell (MSC) Efficacy in Neonatal Hyperoxia-Induced Lung Injury.
    Sammour I; Somashekar S; Huang J; Batlahally S; Breton M; Valasaki K; Khan A; Wu S; Young KC
    PLoS One; 2016; 11(10):e0164269. PubMed ID: 27711256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.